TRxADE Health Receives Non-Compliance Notice From Nasdaq Over Delayed Quarterly Report
Portfolio Pulse from Benzinga Newsdesk
TRxADE Health has received a notice from Nasdaq for not complying with the listing rules due to a delay in filing its quarterly report (Form 10-Q). The company has 60 days to submit a plan to regain compliance and may receive up to 180 days from the original due date to file the report and comply with Nasdaq's rules. TRxADE Health is working to complete and file the Form 10-Q as soon as possible.
November 30, 2023 | 6:56 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TRxADE Health, trading under the symbol MEDS, has been notified by Nasdaq of non-compliance due to a delay in filing its quarterly report. The company is working to submit the report promptly to regain compliance.
Receiving a non-compliance notice from Nasdaq is a negative event that can lead to investor concern about the company's financial health and governance. This may result in a short-term negative impact on the stock price of MEDS. However, the company's intention to file the report as soon as practicable may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100